Glaxo Group Limited
At least 39 active companies
These details are public data from the Companies House register.
Appointments 39 current
Not a complete list. See all appointments on Companies House
Corporate Director · Appointed 30 March 2020
Active
Audit exemption subsidiary accounts · Incorporated 2011
Corporate Director · Appointed 10 July 2013
Active
Small accounts · Incorporated 2013
Corporate Director · Appointed 6 November 2012
Active
Full accounts · Incorporated 2012
Corporate Director · Appointed 6 November 2012
Active
Full accounts · Incorporated 2012
Corporate Director · Appointed 6 November 2012
Active
Full accounts · Incorporated 2012
Corporate Director · Appointed 6 November 2012
Active
Full accounts · Incorporated 2012
Corporate Director · Appointed 5 January 2007
Active
Audit exemption subsidiary accounts · Incorporated 2000
Corporate Director · Appointed 16 August 2006
Active
Dormant accounts · Incorporated 1979 · Pension funding
Corporate Director · Appointed 19 January 2006
Active
Full accounts · Incorporated 2005
Corporate Director · Appointed 5 September 2002
Active
Audit exemption subsidiary accounts · Incorporated 1924
Corporate Director · Appointed 9 July 2002
Active
Full accounts · Incorporated 2002 · None Supplied
Corporate Director · Appointed 9 July 2002
Active
Full accounts · Incorporated 2002 · None Supplied
Corporate Director · Appointed 24 October 2001
Active
Full accounts · Incorporated 2001
Corporate Director · Appointed 4 October 2001
Active
Audit exemption subsidiary accounts · Incorporated 2001
Corporate Director · Appointed 11 June 2001
Active
Full accounts · Incorporated 2001
Corporate Director · Appointed 13 May 2001
Active
Audit exemption subsidiary accounts · Incorporated 1951
Corporate Director · Appointed 15 March 2001
Active
Full accounts · Incorporated 1953
Corporate Director · Appointed 14 March 2001
Active
Audit exemption subsidiary accounts · Incorporated 1993
Corporate Director · Appointed 2 March 2001
Active
Full accounts · Incorporated 1928
Corporate Director · Appointed 2 March 2001
Active
Full accounts · Incorporated 1998
Corporate Director · Appointed 2 March 2001
Active
Audit exemption subsidiary accounts · Incorporated 1990
Corporate Director · Appointed 28 February 2001
Active
Full accounts · Incorporated 1929
Corporate Director · Appointed 28 February 2001
Active
Audit exemption subsidiary accounts · Incorporated 1996
Corporate Director · Appointed 28 February 2001
Active
Audit exemption subsidiary accounts · Incorporated 1935
Corporate Director · Appointed 28 February 2001
Active
Full accounts · Incorporated 1988
Corporate Director · Appointed 19 February 2001
Active
Audit exemption subsidiary accounts · Incorporated 1908
Corporate Director · Appointed 19 February 2001
Active
Audit exemption subsidiary accounts · Incorporated 1988
Corporate Director · Appointed 19 February 2001
Active
Full accounts · Incorporated 1925
Corporate Director · Appointed 16 February 2001
Active
Audit exemption subsidiary accounts · Incorporated 1952
Corporate Director · Appointed 31 January 2001
Active
Full accounts · Incorporated 1972
Corporate Director · Appointed 31 January 2001
Active
Full accounts · Incorporated 1965
Corporate Director · Appointed 31 January 2001
Active
Full accounts · Incorporated 1985
Corporate Director · Appointed 31 January 2001
Active
Audit exemption subsidiary accounts · Incorporated 1904
Corporate Director · Appointed 31 January 2001
Active
Audit exemption subsidiary accounts · Incorporated 1950
Corporate Director · Appointed 31 January 2001
Active
Dormant accounts · Incorporated 1893 · Dormant Company
Corporate Director · Appointed 31 December 2000
Active
Full accounts · Incorporated 1989
Corporate Director · Appointed 29 September 1997
Active
Audit exemption subsidiary accounts · Incorporated 1955
Corporate Director · Appointed 29 September 1997
Active
Dormant accounts · Incorporated 1932 · Dormant Company
Former appointments (19)
Corporate Director · Appointed 31 March 2020 · Resigned 6 April 2022
Company active
Corporate Director · Appointed 2 December 2019 · Resigned 1 April 2022
Company in liquidation
Corporate Director · Appointed 2 December 2019 · Resigned 6 April 2022
Company in liquidation
Corporate Director · Appointed 26 September 2019 · Resigned 6 April 2022
Company active
Corporate Director · Appointed 26 September 2019 · Resigned 6 April 2022
Company active
Corporate Director · Appointed 26 September 2019 · Resigned 6 April 2022
Company active
Corporate Director · Appointed 30 November 2017 · Resigned 6 April 2022
Company in liquidation
Corporate Director · Appointed 4 August 2016 · Resigned 6 April 2022
Company active
Corporate Director · Appointed 3 February 2016 · Resigned 16 November 2016
Company active
Corporate Director · Appointed 2 February 2015 · Resigned 6 April 2022
Company active
Corporate Director · Appointed 21 January 2015 · Resigned 6 April 2022
Company active
Corporate Director · Appointed 6 November 2014 · Resigned 1 April 2022
Company active
Corporate Director · Appointed 26 September 2014 · Resigned 6 April 2022
Company active
Corporate Director · Appointed 26 September 2014 · Resigned 6 April 2022
Company active
Corporate Director · Appointed 26 September 2014 · Resigned 1 April 2022
Company active
Corporate Director · Appointed 21 June 2012 · Resigned 6 April 2022
Company active
Corporate Director · Appointed 1 July 2010 · Resigned 20 April 2011
Company active
Corporate Director · Appointed 18 May 2010 · Resigned 6 December 2023
Company active
Corporate Director · Appointed 13 March 2001 · Resigned 6 April 2022
Company active
Works with
Officers serving alongside Glaxo Group Limited
Bringloe, James, Dr
Bringloe, James, Dr
Director at Smithkline Beecham (Export) Limited
Brogden, Edward Francis
Director at Clarges Pharmaceuticals Trustees Limited
Director at Smithkline Beecham Limited
Caglar, Esra
Director at Glaxosmithkline UK Limited
Davidson, Alistair Robert
Director at Beecham Group PLC